Meroka Raises $6M To Drive Employee Ownership At Independent Medical Practices

Medical Professional

Canva Image

Independent physician practices sit at a crossroads. After two decades of industry consolidation, most physicians now work for hospitals or corporate owners rather than in private practice. Between 2012 and 2024, the share of physicians in private practices fell from 60.1% to 42.2%, reflecting a steady shift toward employment models; by early 2024 roughly three-quarters of physicians were employees of hospitals, health systems, or other corporate entities, with about 22–23% employed by corporate owners. And with rising administrative burden, and reimbursement gaps that favor hospital-owned clinics, many small practices are running as hard as ever and earning less than they did years ago.

Into that headwind, health-tech startup Meroka has raised $6 million in a seed funding round led by Better Tomorrow Ventures & Slow Ventures with participation from 8VC and other investors, to scale an employee stock ownership (ESOP) model that converts physician-owned practices into employee-owned practices with a modern operations stack.

The first cohort includes five OB/GYN practices in five states—small by enterprise standards (3–8 physicians, 15–80 total staff, $3–$10 million in top-line revenue or annual collections), but outsized in community impact (often 100+ patients per day, 15,000–20,000 patients on an annual basis). Early results, Meroka says, show an approximate 5% lift in earnings within six months, with gains driven by higher collections, fewer denials, and targeted cost reductions such as malpractice premiums.

I spoke with CEO Alex Barrett, who describes his mission and vision for a revamped structure of medical practice buy-outs that emphasizes long-term sustainability versus the traditional buy-and-flip script in private equity.

Doctors in Private Practice Are Burned Out

There’s a broad trend of burnout amongst physicians and medical professionals, but for those in private practice, the added layer of being a small business owner adds additional pressures—payroll and hiring, payer contracting and credentialing, prior authorization and revenue cycle, rent and vendor management—so that the clinical strain is compounded by day-to-day operational and financial risk.

Across Meroka’s discovery work, Barrett heard the same refrain:

“I’ve been building this business for 20 or 30 years. I’ve never worked harder than now, and I’ve never made less money. I can’t reconcile that.”

Barrett calls independent practice a “demanded but broken” model. Patients and doctors still want personalized, locally anchored care. Yet, he argues, structural dynamics—particularly reimbursement disparities—have eroded the business case. “You look at reimbursement rates—200–300% lower for an independent practice for the exact same procedure on the exact same street as a large corporate player,” he says.

The result: thin margins (often under 10%, sometimes under 5%). “A provider goes on vacation for two weeks—you don’t make any money that month,” Barrett says. “If the owner wants to take Fridays off, suddenly you’re negative.” Starved for cash, practices defer technology decisions or bolt on point solutions they can’t fully use, never building the integrated data layer that enhances operational processes.

Private Equity Loves a Medical Practice Roll-Up

Enter private equity and the physician practice roll-up.

Roll-ups are deals in which an investor or management company acquires multiple independent practices, centralizes back-office functions (billing, contracting, IT), standardizes operations under one platform, and uses the combined scale to improve margins and payer leverage—typically with a time-bound plan to resell at a higher valuation. Private-equity acquisitions of physician practices grew more than six-fold from 2012 to 2021 (In 2012, there were 75 acquisitions, compared to 484 acquisitions in 2021).

In theory, this strategy is a win for capital and a practical response to operational strain—centralizing back-office work, standardizing tech, and supplying managerial capacity and scale beyond what most independent practices can sustain.

But there’s the timeframe problem: the classic roll-up playbook—buy a platform, bolt on clinics, centralize ops, sell in 4–7 years—can deliver real operating gains, but it also tilts decision-making toward short-term EBITDA optics rather than multi-decade durability, staff satisfaction, and continuity of care. According to Barrett, after the initial integration push, the incentives often point to profit optimization over practice culture and patient experience.

Barrett doesn’t argue that all rollups are bad. But “If you look across the board and you look at the data 20 years later,” he says, “a lot of these rollups result in more profit optimization, lower satisfaction among staff and physicians, and in some cases lower quality of patient care.” When value realization depends on a sale to a bigger buyer at a higher multiple, decision-making tends to compress around what improves the exit, not what builds a durable clinic.

Not surprisingly, physicians express largely negative views about PE’s effects on the health care system, with concerns about physician well-being, health care spending, and health equity.

Meroka is designed for the opposite outcome: no flip, no sponsor dividends, and ownership in the hands of the people working in the practice. That’s the cultural lever that, in Barrett’s view, unlocks the technology lever.

An Alternative Strategy: Employee-Led Buy-Outs and ESOP Ownership Culture

To understand more about employee ownership structures, I spoke with Todd Leverette, Managing Partner of Apis & Heritage (A&H), a private equity fund dedicated to financing employee-led buyouts (ELBOs). Through its Legacy Fund I, A&H has invested in five companies, created over 450 new worker owners, and transferred more than $65 million in enterprise value into employee trusts. In these transactions, A&H does not purchase the company. Instead, alongside bank loans (and, when appropriate, seller financing), A&H provides capital—typically alongside bank financing—so that an Employee Stock Ownership Plan (ESOP) trust can acquire 100% of the company on behalf of employees.

Leverette’s rationale starts with where value is created: “When we think about service-based businesses, like medical practices, most of the value is created with the interaction between the healthcare professionals and the patients. If those creating value become owners, they develop what we call an ownership mindset. The research shows that when you create that alignment you get better outcomes for customers—in this case, better outcomes for patients.” He added that, historically, equity participation has been concentrated in sectors like tech, but the aim now is to extend ownership to the broader economy—manufacturing, construction, plumbing, agriculture—“so essential workers build wealth when the businesses they power succeed.”

That shift is showing up in mainstream private markets as well. Leverette pointed to efforts led by Pete Stavros at KKR, who helped launch Ownership Works in 2021 to expand broad-based employee ownership across portfolio companies. As of 2025, Ownership Works says 147 companies have implemented shared-ownership programs reaching 235,160 employees, with $1.2 billion already paid out to workers and more than $8 billion projected. The coalition now includes dozens of private equity firms—Ownership Works’ 2024 impact report notes partnerships with 32 PE sponsors—and its investor roster features names such as TPG, Warburg Pincus, Leonard Green & Partners, L Catterton, Altamont, Blue Wolf, Tailwind Capital, and Shamrock Capital, each committing to implement broad-based plans in multiple portfolio companies.

Beyond KKR, other large managers have moved in the same direction. Blackstone has announced portfolio-wide initiatives to grant equity to rank-and-file employees—beginning with Copeland—joining a group of sponsors that now publicly promote shared ownership as part of their value-creation playbook. KKR, for its part, reports that roughly 70 of its portfolio companies have awarded equity to nearly 170,000 non-senior employees since 2011, illustrating the scale at which these programs are being deployed.

The mechanics—and the time horizon—matter. In many private-equity “shared ownership” programs, equity is granted directly to employees or pooled for broad participation, and value is realized at exit over a four- to six-year hold. By contrast, ESOPs hold shares in a trust for employees; allocations accrue annually, and employees cash out when they leave the company, whether or not there is a sale. As summarized by the National Center for Employee Ownership, successful PE programs have delivered roughly six to twelve months of pay in equity over a typical hold; ESOP companies, in contrast, often operate plans for decades, with tax advantages (for example, 100% ESOP-owned S-corps generally pay no federal income tax) that can compound wealth for long-tenured workers.

Leverette emphasized that performance differences stem less from the legal wrapper than from the culture that’s built around it. “There’s something called ownership culture that we focus on cultivating with our portfolio companies,” he said. The approach includes a menu of practices: governance that gives workers a real voice (A&H places an employee representative on the board in its companies); open-book management, sharing financials and key operating metrics and teaching people how their roles influence outcomes; and human-centered HR that treats workers as owners—structured feedback channels, manager training, and annual worker surveys to close the loop.

“The stats show that if you take two businesses in the same industry, same size, same place—make one of them worker-owned and keep the other under traditional ownership—the worker-owned firm tends to grow faster, turn over fewer employees, and deliver better life outcomes for workers,” he said.

Stavros has framed the larger ambition succinctly: employee ownership, he said, “could give us a form of capitalism that is actually inclusive and sustainable. And I believe it could literally change the economy.”

Meroka’s Healthcare-Focused ESOP Model

Meroka’s employee ownership model has a similarly-mission driven approach. The startup tested their thesis with OB/GYN clinics – as this is the largest subspecialty by volume and, in Barrett’s view, home to mission-driven physicians who entered medicine to care for patients, not to chase fee differentials. “The average salary of an OB in the U.S. starts with a 2,” Barrett notes—roughly half that of some procedure-heavy specialties—while the work is grueling: long call shifts, overnight coverage, relentless scheduling complexity.

The practices Meroka targets share a specific profile: solo or family ownership, often 20–30 years in operation; an owner nearing retirement who wants to fully exit on a two- to five-year timeline; and a team of nurses, receptionists, billers, and associate physicians who hold the place together day to day. “These are small businesses,” Barrett says, “but they punch above their weight in the community.”

For each practice, the company sets up an employee ownership trust and a compliant management services organization (MSO). The trust owns the MSO outright, and every person in the practice—physicians and nonclinical staff—participates as a beneficiary. Meroka doesn’t take an equity stake in that entity and doesn’t draw from practice profits; its economics live elsewhere, in the technology support services it provides.

A key choice is how quickly employees receive the benefits. As Barrett puts it, “we can start paying out distributions after the first year if we wanted to…since there’s no vesting,” which is a bit of an anomaly in the ESOP world. But Meroka’s intent is to make ownership feel “real” early on. “People on the ground don’t believe it until they get their first distribution check.”

Ownership percentages are also tailored, not one-size-fits-all. Meroka brings a template, and each practice adjusts allocations by role and merit. Stakes are set aside for future hires—both physicians and staff—so the structure doesn’t freeze on day one. The team also calls out certain integral roles that may not be medical, but that hold a practice together, like an office manager who keeps the day moving, and gives them room for outsized equity allocation.

On the transaction side, the selling physician (or family owner) transfers 100% of the practice at signing. Cash at close varies by situation—typically somewhere between 20% and 90%—with the remainder paid over time and tied to future performance and transition risk. To date, Meroka has funded transactions from its balance sheet; but as the model scales, Barrett said the company will explore bank and other financing to better match duration and risk.

Meroka’s Back-Office Play: Revenue Optimization via Tech Adoption

Meroka’s business model is different from most private-equity players in the ESOP space, who typically monetize through fund- and portfolio-level management/monitoring and transaction fees, earn interest (and sometimes warrants) on ESOP financing, and seek equity upside at exit. By contrast, Meroka earns its fees from operational efficiencies—carving its compensation out of the costs it reduces in the back office. And Barrett’s professional background in accounting and finance (he has a CFA and CPA) certainly come into play.

Employee KPI Dashboard

Courtesy of Meroka

Barrett elaborates, in most small practices, the finances are very simple, and the bulk of costs are concentrated in a handful of line items—payroll, medical supplies, EHR, malpractice insurance, and rent—leaving little room for additional vendors. For functions like billing/RCM and accounting, Meroka asks practices to route the same dollars they already pay to vendors, through Meroka instead. As Barrett describes it, if a clinic pays $100,000 annually for billing, that payment is redirected to Meroka; Meroka then decides how to perform the work and seeks to earn margin through automation and process control on the back end.

For malpractice and supplies, the company pursues rate negotiations across its client base. In one example, a practice saved about $70,000 annually on malpractice premiums. Payroll and rent are generally outside scope.

The technology revamp centers on a data consolidation layer that connects the clinic’s EMR, accounting system, payroll, and document stores (policies, SOPs, PDFs). With that “digital instance” in place, Meroka “orchestrates” point solutions for specific revenue-cycle steps—eligibility checks, prior authorization, coding optimization, scribing, credentialing, denial management—and maintains the integrations. Barrett’s view is that many best-in-class vendors do not sell into small private practices directly, so Meroka acts as the integration and management layer a small practice typically lacks.

The company measures impact primarily through the collections rate, where those processes converge. Barrett estimates that independent clinics commonly collect ~60–70% of billable charges. With unified data and automated routing, Meroka targets 85%+ collections. In its first cohort, the company reports an approximately 5% earnings increase within six months, alongside case-by-case cost reductions from vendor renegotiations.

Keeping with the theme of worker transparency and ownership mindset that Leverette outlined, Meroka runs monthly financial reviews with staff and publishes KPI boards—patients, appointments, charges, collections, denial reasons, days in A/R—so employees can see how specific workflows affect results.

If a practice isn’t profitable, that is visible to the team. The premise is that transparent metrics, coupled with the trust’s distribution policy, support consistent use of the tooling and processes that drive the revenue-cycle changes on which the model relies.

Challenges With Underwriting Risky Assets

There is a reasonable skepticism to bring to any model built on improving underperforming small businesses.

A useful parallel is Teamshares, which was founded in 2019 and as of June 2025, has purchased more than 95 small businesses and transitioned them to employee ownership. Backed by $245 million in venture capital and $225 million in debt, they have set out to create 10,000 employee-owned companies and $10 billion of employee stock.

Unlike Meroka, Teamshares earns money from equity ownership and plan administration: (1) portfolio-company fees for stock/equity plan administration; (2) profit distributions on its retained equity stake; and (3) cash from scheduled company repurchases of Teamshares-held shares at fair-market value, which reduce Teamshares’ stake over time as employee ownership rises.

But like Meroka, Teamshares pairs the ownership transition with a shared-services, tech-enabled operating layer—centralizing accounting, payroll, and vendor contracting (and, in healthcare contexts, billing/RCM) to standardize processes and lift collections.”

The central question observers raise about that approach—is whether the kinds of companies being acquired can generate enough durable profit to satisfy outside investors seeking competitive returns. Transformations are hard, and thin-margin local businesses do not leave much room for error.

Barrett is explicit about why these assets are “ignored” in conventional deal processes. “The historical valuation model has all been about cash flows,” he told me. “Every buyer I know starts by figuring out true EBITDA, then applies a multiple. That’s why a lot of the practices we work with are still private—there’s not a lot of earnings to value. Chances are they either haven’t gone to market because they know that, or they’ve tried and been told ‘no.’ They get stuck in a downward spiral of having ‘no enterprise value.’” Meroka’s underwriting turns that on its head: “We try to value future potential. We don’t value the practice on historicals.” In other words, the consideration is tied to what the clinic can become once basic operational work—collections, denials, coding, credentialing—improves.

That future-value stance shows up in how Meroka structures transactions. Sellers transfer 100% of the practice at signing; cash at close ranges from about 20% to 100% of the agreed value, based on the readiness of the business and the team’s confidence in the transition plan. The remainder is paid over time and tied to the practice’s trajectory.

Up to this point, Meroka has funded these buyouts from its balance sheet i.e., venture dollars raised, which has allowed it to work with clinics that traditional lenders and buyers often pass over. The open question is scale: as volumes grow, Meroka will need to raise much more capital, while also introducing third-party debt without undermining its core commitment—100% employee-trust ownership of the MSO and no sponsor dividends at the practice level. Cost of capital, interest-rate sensitivity, and lender comfort with forward-looking underwriting will matter.

There are other execution risks to acknowledge. The model depends on adoption—moving collections from ~60–70% toward 85%+ and keeping it there; maintaining staffing and physician succession; and avoiding “change fatigue” as tools and processes are upgraded. Because Meroka does not take an equity dividend, its economics live in the services margin it earns by running back-office functions better than the status quo. If adoption stalls, the financial cushion is thin.

Still, there are reasons to think the wager is rational. The early indicators—an approximate 5% earnings lift across the first cohort, meaningful savings on malpractice and supplies, and tighter KPI discipline—suggest that basic operational repairs can move the needle even in small clinics.

The ownership design is meant to accelerate that repair work. As Leverette of Apis & Heritage told me, “When the people who create the value become owners, they develop an ownership mindset. The research shows that when you create that alignment, you get better outcomes for customers—in healthcare, better outcomes for patients.” Making ownership tangible early through distributions, sharing the scoreboard (collections, denials, days in A/R), and giving workers a real voice in governance are the cultural mechanics that support the financial thesis.

Meroka is making a venture-style bet inside a traditional private equity lane by underwriting clinics for what they can be, not what last year’s P&L says they are. It is not a guaranteed path, and the capital stack will need to mature as the company grows. But if the early pattern holds—modest, repeatable improvements in revenue cycle and cost leakage, paired with steady distributions that staff can see and feel—the ESOP model offers a credible way to keep more private practices independent while building wealth for the people who keep them running. In a part of the system where the alternative is often consolidation or closure, that is an outcome worth testing at scale.